Lung Cancer Trial, Recruiting NCT04595422 Sponsor: M.D. Anderson Cancer Center Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT04595422
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For quitline call center staff:

  • People who work at a quitline call center
  • People aged 18 years or older

For callers (people who contact a quitline about quitting smoking):

  • People between 55 and 80 years of age
  • People who currently smoke, or who stopped smoking less than 15 years ago
  • People who have a smoking history of 30 pack-years or more (this is a measure of how much someone has smoked over their lifetime — confirm with trial site if unsure how this applies)
  • People who speak English

Who may not be able to join:

For callers (people who contact a quitline about quitting smoking):

  • People who report having had lung cancer in the past

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Robert J Volk, M.D. Anderson Cancer Center

Phone: 713-563-0020

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 July 2020
Est. completion
31 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Content from communications (email, phone, monthly calls); Healthcare sector perspective; Reach; Overall lung cancer screening rate; Effectiveness (Caller Substudy)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov